The DOI matches its Crossref record; 240 of the 240 references it cites were found in a registry or an index.
Is dehydroepiandrosterone a hormone?
Abstract
Dehydroepiandrosterone (DHEA) is not a hormone but it is a very important prohormone secreted in large amounts by the adrenals in humans and other primates, but not in lower species. It is secreted in larger quantities than cortisol and is present in the blood at concentrations only second to cholesterol. All the enzymes required to transform DHEA into androgens and/or estrogens are expressed in a cell-specific manner in a large series of peripheral target tissues, thus permitting all androgen-sensitive and estrogen-sensitive tissues to make locally and control the intracellular levels of sex steroids according to local needs. This new field of endocrinology has been called intracrinology. In women, after menopause, all estrogens and almost all androgens are made locally in peripheral tissues from DHEA which indirectly exerts effects, among others, on bone formation, adiposity, muscle, insulin and glucose metabolism, skin, libido and well-being. In men, where the secretion of androgens by the testicles continues for life, the contribution of DHEA to androgens has been best evaluated in the prostate where about 50% of androgens are made locally from DHEA. Such knowledge has led to the development of combined androgen blockade (CAB), a treatment which adds a pure anti-androgen to medical (GnRH agonist) or surgical castration in order to block the access of the androgens made locally to the androgen receptor. In fact, CAB has been the first treatment demonstrated to prolong life in advanced prostate cancer while recent data indicate that it can permit long-term control and probably cure in at least 90% of cases of localized prostate cancer. The new field of intracrinology or local formation of sex steroids from DHEA in target tissues has permitted major advances in the treatment of the two most frequent cancers, namely breast and prostate cancer, while its potential use as a physiological HRT could well provide a physiological balance of androgens and estrogens, thus offering exciting possibilities for women’s health at menopause.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sexual Dysfunction in the United States: Prevalence and Predictors
Laumann, E. O., Paik, A., & Rosen, R. C. (1999) · JAMA · doi:10.1001/jama.281.6.537 · Cited by 5,119
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
Grady, D., Rubin, S. M., Petitti, D. B., Fox, C. S., Black, D., Ettinger, B., Ernster, V. L., & Cummings, S. R. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-1016 · Cited by 2,336
Cummings, S. R., Eckert, S., Krueger, K. A., Grady, D., Powles, T. J., Cauley, J. A., Norton, L., Nickelsen, T., Bjarnason, N. H., Morrow, M., et al. (1999) · JAMA · doi:10.1001/jama.281.23.2189 · Cited by 1,872
Goss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032312 · Cited by 1,795
Bolla, M., Gonzalez, D., Warde, P., Dubois, J. B., Mirimanoff, R.-O., Storme, G., Bernier, J., Kuten, A., Sternberg, C., Gil, T., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370502 · Cited by 1,548
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487 · cited 1×
“…proliferation, thus avoiding the recently demonstrated stimulatory effect of progestins on breast cancer (Bergkvist et al. 1989, Clarke & Sutherland 1990, Musgrove et al. 1991, Horwitz 1992, Colditz et al. 1995, Magnusson et al. 1999, Persson 1999, Ross et al. 2000, Women’s Health Initiative 2002).”
BackgroundA Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
Crawford, E. D., Eisenberger, M. A., McLeod, D. G., Spaulding, J. T., Benson, R., Dorr, F. A., Blumenstein, B. A., Davis, M. A., & Goodman, P. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908173210702 · Cited by 1,464
ORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349
Messing, E. M., Manola, J., Sarosdy, M., Wilding, G., Crawford, E. D., & Trump, D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912093412401 · Cited by 1,191
Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., Belanger, A., Gigleux, S. F., Green, M., Hum, D. W., Iyanagi, T., et al. (1997) · Pharmacogenetics · doi:10.1097/00008571-199708000-00001 · Cited by 1,183
Self-citationNabholtz, J. M., Buzdar, A., Pollak, M., Harwin, W., Burton, G., Mangalik, A., Steinberg, M., Webster, A., & von Euler, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.22.3758 · Cited by 992
Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.
Shifren, J. L., Braunstein, G. D., Simon, J. A., Casson, P. R., Buster, J. E., Redmond, G. P., Burki, R. E., Ginsburg, E. S., Rosen, R. C., Leiblum, S. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431002 · Cited by 954
Effect of Hormone Replacement Therapy on Breast Cancer Risk: Estrogen Versus Estrogen Plus Progestin
Ross, R. K. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.4.328 · Cited by 877
Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
Morales, A. J., Nolan, J. J., Nelson, J. C., & Yen, S. S. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.6.7515387 · Cited by 841
Cummings, S. R. (1999) · Medical Entomology and Zoology · Cited by 797
Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of Estrogen
Weiss, N. S., Ure, C. L., Ballard, J. H., Williams, A. R., & Daling, J. R. (1980) · New England Journal of Medicine · doi:10.1056/nejm198011203032102 · Cited by 775
Mouridsen, H., Gershanovich, M., Sun, Y., Pérez-Carrión, R., Boni, C., Monnier, A., Apffelstaedt, J., Smith, R., Sleeboom, H. P., Jaenicke, F., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.194 · Cited by 746
Labrie, F., Bélanger, A., Cusan, L., Gomez, J.-L., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4160 · Cited by 713
Self-citationProgestin regulation of cellular proliferation.
CLARKE, C. L., & SUTHERLAND, R. L. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-2-266 · Cited by 650 · cited 1×
“…against endometrial proliferation, thus avoiding the recently demonstrated stimulatory effect of progestins on breast cancer (Bergkvist et al. 1989, Clarke & Sutherland 1990, Musgrove et al. 1991, Horwitz 1992, Colditz et al. 1995, Magnusson et al. 1999, Persson 1999, Ross et al. 2000, Women’s…”
BackgroundDehydroepiandrosterone Replacement in Women with Adrenal Insufficiency
Arlt, W., Callies, F., van Vlijmen, J. C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettel, M., Ernst, M., Schulte, H. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411401 · Cited by 644
The Risk of Breast Cancer after Estrogen and Estrogen–Progestin Replacement
Bergkvist, L., Adami, H.-O., Persson, I., Hoover, R., & Schairer, C. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210505 · Cited by 613
Pilepich, M. V., Caplan, R., Byhardt, R. W., Lawton, C. A., Gallagher, M. J., Mesic, J. B., Hanks, G. E., Coughlin, C. T., Porter, A., Shipley, W. U., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.1013 · Cited by 607
Baulieu, E.-E., Thomas, G., Legrain, S., Lahlou, N., Roger, M., Debuire, B., Faucounau, V., Girard, L., Hervy, M.-P., Latour, F., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4279 · Cited by 577
Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3
Geissler, W. M., Davis, D. L., Wu, L., Bradshaw, K. D., Patel, S., Mendonca, B. B., Elliston, K. O., Wilson, J. D., Russell, D. W., & Andersson, S. (1994) · Nature Genetics · doi:10.1038/ng0594-34 · Cited by 570
Labrie, F., Luu-The, V., Labrie, C., Bélanger, A., Simard, J., Lin, S.-X., & Pelletier, G. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0031 · Cited by 544 · cited 7×
“…the inconclusive studies on the role of androgens in women under various clinical conditions (Leiblum et al. 1983, Garland et al. 1992, Lipworth et al. 1996, Laughlin & Barrett-Connor 2000, Couzinet et al. 2001, Davis & Tran 2001, Labrie et al. 2003a, Miller et al. 2004, Tchernof & Labrie 2004).”
BackgroundInfluentialSelf-citationTestosterone enhances estradiol's effects on postmenopausal bone density and sexuality
Davis, S. R., McCloud, P., Strauss, B. J. G., & Burger, H. (1995) · Maturitas · doi:10.1016/0378-5122(94)00898-h · Cited by 533
Andersson, S., & Russell, D. W. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3640 · Cited by 501
Bachmann, G., Bancroft, J., Braunstein, G., Burger, H., Davis, S., Dennerstein, L., Goldstein, I., Guay, A., Leiblum, S., Lobo, R., et al. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)02969-2 · Cited by 444
Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men
Belanger, A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.4.1086 · Cited by 438
Self-citationWu, L., Einstein, M., Geissler, W. M., Chan, H. K., Elliston, K. O., & Andersson, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31480-7 · Cited by 437
NESTLER, J. E., BARLASCINI, C. O., CLORE, J. N., & BLACKARD, W. G. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-57 · Cited by 414
The role of androgen in the maintenance of sexual functioning in oophorectomized women.
Sherwin, B. B., & Gelfand, M. M. (1987) · Psychosomatic Medicine · doi:10.1097/00006842-198707000-00009 · Cited by 394 · cited 4×
“It is believed that low serum free testosterone is the diagnostic marker of ‘female androgen insufficiency’ (Bachmann et al. 2002) as indicated in some studies (Sherwin & Gelfand 1987, Davis et al. 1995, Shifren et al. 2000, Goldstat et al. 2003) and by expert opinions (Cameron & Braunstein 2004).”
BackgroundInfluentialENDOCRINE CONTROL OF PROSTATIC CARCINOMA: Clinical and Statistical Survey of 1,818 Cases
NESBIT, R. M. (1950) · Journal of the American Medical Association · doi:10.1001/jama.1950.02910500019005 · Cited by 371
Labrie, F., Luu-The, V., Labrie, C., & Simard, J. (2001) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0216 · Cited by 366
Self-citationRhéaume, E., Lachance, Y., Zhao, H.-F., Breton, N., Dumont, M., Launoit, Y. D., Trudel, C., Luu-The, V., Simard, J., & Labrie, F. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-8-1147 · Cited by 362
Self-citationLabrie, F., Bélanger, A., Cusan, L., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4161 · Cited by 350
Self-citationTurgeon, D., Carrier, J.-S., Lévesque, E., Hum, D. W., & Bélanger, A. (2001) · Endocrinology · doi:10.1210/endo.142.2.7958 · Cited by 333
Studies in the Distribution of Body Fat: I. Effects of Age, Sex, and Obesity
Shimokata, H., Tobin, J. D., Muller, D. C., Elahi, D., Coon, P. J., & Andres, R. (1989) · Journal of Gerontology · doi:10.1093/geronj/44.2.m66 · Cited by 319
Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice.
Coleman, D. L., Leiter, E. H., & Schwizer, R. W. (1982) · Diabetes · doi:10.2337/diab.31.9.830 · Cited by 317 · cited 2×
“…in the formation of androgens and estrogens in peripheral target tissues, which could well be involved in the pathogenesis of age-related diseases such as insulin resistance (Coleman et al. 1982, Schriock et al. 1988) and obesity (Nestler et al. 1988, MacEwen & Kurzman 1991, Tchernof et al. 1995).”
BackgroundGoss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000115858.45890.53 · Cited by 315
Insulin Resistance, Hyperinsulinemia, and Blood Pressure: Role of Age and Obesity
Ferrannini, E., Natali, A., Capaldo, B., Lehtovirta, M., Jacob, S., & Yki-Järvinen for the European Group for the Study of Insuli, H. (1997) · Hypertension · doi:10.1161/01.hyp.30.5.1144 · Cited by 315
The, V. L., Lachance, Y., Labrie, C., Leblanc, G., Thomas, J. L., Strickler, R. C., & Labrie, F. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-8-1310 · Cited by 309
Self-citationMiller, K. K., Rosner, W., Lee, H., Hier, J., Sesmilo, G., Schoenfeld, D., Neubauer, G., & Klibanski, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030680 · Cited by 301 · cited 2×
“…low sexual desire www.endocrinology-journals.orgJournal of Endocrinology (2005) 187, 169–196 Downloaded from Bioscientifica.com at 08/04/2019 02:47:48PM via free access (Dennerstein et al. 1997), it is believed that low androgens play an independent role (Bachmann et al. 2002, Miller et al. 2004).”
BackgroundGoldstat, R., Briganti, E., Tran, J., Wolfe, R., & Davis, S. R. (2003) · Menopause · doi:10.1097/01.gme.0000060256.03945.20 · Cited by 296
Complete amino acid sequence of human placental 17β-hydroxysteroid dehydrogenase deduced from cDNA
Peltoketo, H., Isomaa, V., Mäentausta, O., & Vihko, R. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80548-9 · Cited by 294
Labrie, F., Diamond, P., Cusan, L., Gomez, J.-L., Bélanger, A., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4306 · Cited by 292
Self-citationComplete androgen blockade for the treatment of prostate cancer.
Labrie, F., Dupont, A., & Bèlanger, A. (1985) · PubMed · Cited by 281
Self-citationDHEA and peripheral androgen and estrogen formation: intracrinology
LABRIE, F., BÉLANGER, A., SIMARD, J., LUU‐THE, V., & LABRIE, C. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17369.x · Cited by 280
Self-citationLabrie, F., Luu-The, V, Lin, S., Simard, J., Labrie, C., El-Alfy, M., Pelletier, G., & Belanger, A. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250001 · Cited by 278
Self-citationRaisz, L. G. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.1.37 · Cited by 278
Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells.
Suzuki, T., Suzuki, N., Daynes, R. A., & Engleman, E. G. (1991) · Clinical Immunology and Immunopathology · doi:10.1016/s0090-1229(05)80024-8 · Cited by 277
Labrie, F., Dupont, A., Bèlanger, A., Cusan, L., Lacourcière, Y., Monfette, G., LaBerge, J., Emond, J., Fazekas, A. T. A., Raynaud, J., et al. (1982) · PubMed · Cited by 276
Self-citationThe, V. L., Labrie, C., Zhao, H. F., Couët, J., Lachance, Y., Simard, J., Leblanc, G., Côtè, J., Bérubé, D., Gagné, R., et al. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-8-1301 · Cited by 274
Self-citationWilson, J. D., & Walker, J. D. (1969) · Journal of Clinical Investigation · doi:10.1172/jci105994 · Cited by 272
Vaginal atrophy in the postmenopausal woman. The importance of sexual activity and hormones
Leiblum, S. R. (1983) · JAMA · doi:10.1001/jama.249.16.2195 · Cited by 263
Sherwin, B. B., & Gelfand, M. M. (1985) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(85)90001-8 · Cited by 261
MIGEON, C. J., KELLER, A. R., LAWRENCE, B., & SHEPARD, T. H. (1957) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-17-9-1051 · Cited by 260 · cited 4×
“…physiology has removed attention from the dramatic 70% fall in circulating DHEA which already occurs between the ages of 20 to 30 and 40 to 50 years (Migeon et al. 1957, Vermeulen & Verdonck 1976, Vermeulen et al. 1982, Orentreich et al. 1984, Bélanger et al. 1994, Labrie et al. 1997d) (Fig.”
BackgroundInfluentialRisks of breast and endometrial cancer after estrogen and estrogen–progestin replacement
Persson, I., Weiderpass, E., Bergkvist, L., Bergström, R., & Schairer, C. (1999) · Cancer Causes & Control · doi:10.1023/a:1008909128110 · Cited by 258
Affective changes with estrogen and androgen replacement theraphy in surgically menopausal women
Sherwin, B. B. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90061-4 · Cited by 258
Characteristics of a Highly Labile Human Type 5 17β-Hydroxysteroid Dehydrogenase1
Dufort, I., Rheault, P., Huang, X.-F., Soucy, P., & Luu-The, V. (1999) · Endocrinology · doi:10.1210/endo.140.2.6531 · Cited by 255
Self-citationAnalysis and characteristics of multiple types of human 17β-hydroxysteroid dehydrogenase
Luu-The, V. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00155-2 · Cited by 247
Self-citationVillareal, D. T., & Holloszy, J. O. (2004) · JAMA · doi:10.1001/jama.292.18.2243 · Cited by 241
Lobo, R. A., Rosen, R. C., Yang, H.-M., Block, B., & Van Der Hoop, R. G. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00358-3 · Cited by 241
Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans
Bélanger, A., Pelletier, G., Labrie, F., Barbier, O., & Chouinard, S. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2003.10.005 · Cited by 235
Rhéaume, E., Simard, J., Morel, Y., Mebarki, F., Zachmann, M., Forest, M. G., New, M. I., & Labrie, F. (1992) · Nature Genetics · doi:10.1038/ng0792-239 · Cited by 235
Self-citationContribution of visceral fat mass to the insulin resistance of aging
Cefalu, W. T., Wang, Z. Q., Werbel, S., Bell-Farrow, A., Crouse, J. R., Hinson, W. H., Terry, J. G., & Anderson, R. (1995) · Metabolism · doi:10.1016/0026-0495(95)90251-1 · Cited by 228
Prevention of obesity in Avy/a mice by dehydroepiandrosterone
Yen, T. T., Allan, J. A., Pearson, D. V., Action, J. M., & Greenberg, M. M. (1977) · Lipids · doi:10.1007/bf02533624 · Cited by 228
Luu-The, V., Zhang, Y., Poirier, D., & Labrie, F. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00209-x · Cited by 224
Self-citationBiswas, M. G., & Russell, D. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.15959 · Cited by 224
HORWITZ, K. B. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-2-146 · Cited by 221
GRANFORS, T., MODIG, H., DAMBER, J.-E., & TOMIC, R. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)63235-x · Cited by 218
Molecular cloning of a novel widely expressed human 80 kDa 17 β -hydroxysteroid dehydrogenase IV
Adamski, J., Normand, T., Leenders, F., Monté, D., Begue, A., Stéhelin, D., Jungblut, P. W., & de Launoit, Y. (1995) · Biochemical Journal · doi:10.1042/bj3110437 · Cited by 214
Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women
Casson, P. R., Andersen, R. N., Herrod, H. G., Stentz, F. B., Straughn, A. B., Abraham, G. E., & Buster, J. E. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90431-h · Cited by 213
Bélanger, B., Bélanger, A., Labrie, F., Dupont, A., Cusan, L., & Monfette, G. (1989) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(89)90514-1 · Cited by 212
The Postmenopausal Ovary Is Not a Major Androgen-Producing Gland
Couzinet, B., Meduri, G., Lecce, M. G., Young, J., Brailly, S., Loosfelt, H., Milgrom, E., & Schaison, G. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7900 · Cited by 211
CHRISTIANSEN, C., CHRISTENSEN, M. S., LARSEN, N.-E., & TRANSBØL, I. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-6-1124 · Cited by 209
Caubet, J.-F., Tosteson, T. D., Dong, E. W., Naylon, E. M., Whiting, G. W., Ernstoff, M. S., & Ross, S. D. (1997) · Urology · doi:10.1016/s0090-4295(96)00325-1 · Cited by 204
Lachance, Y., Luu-The, V, Labrie, C., Simard, J., Dumont, M., de Launoit, Y., Guérin, S., Leblanc, G., & Labrie, F. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30528-8 · Cited by 201
Self-citationPoulin, R., & Labrie, F. (1986) · PubMed · Cited by 201
Self-citationPatients' choice of treatment in stage D prostate cancer
Cassileth, B. R., Seidmon, E. J., Soloway, M. S., Hait, H. I., Vogelzang, N. J., Kennealey, G. T., & Schellhammer, P. S. (1989) · Urology · doi:10.1016/0090-4295(89)90108-8 · Cited by 201
Antifertility Effects of LHRH Agonists in the Male
LABRIE, F., BÉLANGER, A., CUSAN, L., SEGUIN, C., PELLETIER, G., KELLY, P. A., REEVES, J. J., LEFEBVRE, F., LEMAY, A., GOURDEAU, Y., et al. (1980) · Journal of Andrology · doi:10.1002/j.1939-4640.1980.tb00034.x · Cited by 195
Self-citationSexuality, hormones and the menopausal transition
Dennerstein, L., Dudley, E. C., Hopper, J. L., & Burger, H. (1997) · Maturitas · doi:10.1016/s0378-5122(96)01093-6 · Cited by 191
Martel, C., Meiner, M. H., Gagné, D., Simarda, J., & Labrie, F. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90056-6 · Cited by 190
Self-citationBeaulieu, M., Lávesque, E., Hum, D. W., & Bálanger, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22855 · Cited by 187
Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies
Tchernof, A., & Labrie, F. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510001 · Cited by 187
Self-citationBurger, H. G., Hailes, J., Menelaus, M., Nelson, J., Hudson, B., & Balazs, N. (1984) · Maturitas · doi:10.1016/0378-5122(84)90008-2 · Cited by 187
Dehydroepiandrosterone Replacement in Aging Humans1
Flynn, M. A., Weaver-Osterholtz, D., Sharpe-Timms, K. L., Allen, S., & Krause, G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5672 · Cited by 186
Nokelainen, P., Peltoketo, H., Vihko, R., & Vihko, P. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.7.0134 · Cited by 183
Janknegt, R. A., Abbou, C. C., Bartoletti, R., Bernstein-Hahn, L., Bracken, B., Brisset, J. M., Calais Da Silva, F., Chisholm, G., Crawford, E. D., Debruyne, F. M. J., et al. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)36003-2 · Cited by 181
Cusan, L., Dupont, A., Gomez, J.-L., Tremblay, R. R., & Labrie, F. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56518-2 · Cited by 178
Self-citationPeeling, W. B. (1989) · Urology · doi:10.1016/0090-4295(89)90106-4 · Cited by 178
Zhao, H. F., Labrie, C., Simard, J., de Launoit, Y., Trudel, C., Martel, C., Rhéaume, E., Dupont, E., Luu-The, V, & Pelletier, G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52475-3 · Cited by 176
Self-citationMusgrove, E. A., Lee, C. S., & Sutherland, R. L. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.10.5032 · Cited by 175
Reduced testosterone and adrenal C19 steroid levels in obese men
Tchernof, A., Després, J.-P., Bélanger, A., Dupont, A., Prud'homme, D., Moorjani, S., Lupien, P. J., & Labrie, F. (1995) · Metabolism · doi:10.1016/0026-0495(95)90060-8 · Cited by 175 · cited 2×
“…in the formation of androgens and estrogens in peripheral target tissues, which could well be involved in the pathogenesis of age-related diseases such as insulin resistance (Coleman et al. 1982, Schriock et al. 1988) and obesity (Nestler et al. 1988, MacEwen & Kurzman 1991, Tchernof et al. 1995).”
BackgroundSelf-citationMurphy, G. P., Beckley, S. A., Brady, M. F., Chu, T. M., deKernion, J. B., Dhabuwala, C. B., Gaeta, J. F., Gibbons, R. P., Loening, S. A., McKiel, C. F., et al. (1983) · Cancer · doi:10.1002/1097-0142(19830401)51:7<1264::aid-cncr2820510716>3.0.co;2-u · Cited by 174
Structure of two in tandem human 17β-hydroxysteroid dehydrogenase genes
Luu-The, V., Labrie, C., Simard, J., Lachance, Y., Zhao, H.-F., Couët, J., Leblanc, G., & Labrie, F. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-2-268 · Cited by 173
Self-citationPoulin, R., Baker, D., & Labrie, F. (1988) · Breast Cancer Research and Treatment · doi:10.1007/bf01805942 · Cited by 172
Self-citationLaughlin, G. A., & Barrett-Connor, E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6861 · Cited by 172
Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance
Bulun, S., Zeitoun, K., Takayama, K., & Sasano, H. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250035 · Cited by 172
Effects of DHEA replacement on bone mineral density and body composition in elderly women and men
Villareal, D. T., Holloszy, J. O., & Kohrt, W. M. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01131.x · Cited by 170
Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate.
LABRIE, C., BELANGER, A., & LABRIE, F. (1988) · Endocrinology · doi:10.1210/endo-123-3-1412 · Cited by 167
Self-citationMaximal Androgen Blockade: Final Analysis of EORTC Phase III Trial 30853
Denis, L. J., Keuppens, F., Smith, P. H., Whelan, P., Carneiro de Moura, J. L., Newling, D., Bono, A., Sylvester, R., & EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center, F. T. (1998) · European Urology · doi:10.1159/000019546 · Cited by 167
Stanozolol in postmenopausal osteoporosis: Therapeutic efficacy and possible mechanisms of action
Chesnut, C. H., Ivey, J. L., Gruber, H. E., Matthews, M., Nelp, W. B., Sisom, K., & Baylink, D. J. (1983) · Metabolism · doi:10.1016/0026-0495(83)90027-6 · Cited by 165
Role of 17β-Hydroxysteroid Dehydrogenases in Sex Steroid Formation in Peripheral Intracrine Tissues
Labrie, F., Luu-The, V., Lin, S., Simard, J., & Labrie, C. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00342-8 · Cited by 163
Self-citationControl of secretion and the function of C19-Δ5-steroids of the human adrenal gland
Adams, J. B. (1985) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(85)90138-8 · Cited by 161
Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone.
Gordon, G. B., Shantz, L. M., & Talalay, P. (1987) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(87)90023-9 · Cited by 159
Effect of testosterone therapy on bone formation in an osteoporotic hypogonadal male
Baran, D. T., Bergfeld, M. A., Teitelbaum, S. L., & Avioli, L. V. (1978) · Calcified Tissue Research · doi:10.1007/bf02013243 · Cited by 159
THE METABOLISM OF TESTOSTERONE BY HUMAN MALE SCALP SKIN
Bingham, K. D., & SHAW, D. A. (1973) · Journal of Endocrinology · doi:10.1677/joe.0.0570111 · Cited by 153
Hanks, G. E., Lu, J., Machtay, M. X., Venkatesan, V. M., Pinover, W. H., Byhardt, R. W., & Rosenthal, S. A. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)80021-8 · Cited by 153
Dehydroepiandrosterone Supplementation Improves Endothelial Function and Insulin Sensitivity in Men
Kawano, H., Yasue, H., Kitagawa, A., Hirai, N., Yoshida, T., Soejima, H., Miyamoto, S., Nakano, M., & Ogawa, H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021603 · Cited by 152
Jenkins, E. P., Hsieh, C., Milatovich, A., Normington, K., Berman, D. M., Francke, U., & Russell, D. W. (1991) · Genomics · doi:10.1016/0888-7543(91)90038-g · Cited by 150
CLINICAL EXPERIENCE OF DRUG TREATMENTS FOR MASTALGIA
Pye, J. K., Mansel, R. E., & Hughes, L. E. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92506-1 · Cited by 146
Dijkman, G. A., Janknegt, R. A., de Reijke, T. M., & Debruyne, F. M. J. (1997) · The Journal of Urology · doi:10.1097/00005392-199707000-00051 · Cited by 145
Benz, D., Haussler, M. R., Thomas, M. A., Speelman, B. A., & Komm, B. S. (1991) · Endocrinology · doi:10.1210/endo-128-6-2723 · Cited by 139
Arlt, W., Callies, F., Koehler, I., van Vlijmen, J. C., Faßnacht, M., Strasburger, C. J., Seibel, M. J., Huebler, D., Ernst, M. E., Oettel, M., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7974 · Cited by 139
Lévesque, É., Turgeon, D. K., Carrier, J.-S., Montminy, V., Beaulieu, M., & Bélanger, A. (2001) · Biochemistry · doi:10.1021/bi002607y · Cited by 137
Adrenocortical function in old age: response to acute adrenocorticotropin stimulation.
VERMEULEN, A., DESLYPERE, J. P., SCHELFHOUT, W., VERDONCK, L., & RUBENS, R. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-1-187 · Cited by 135 · cited 3×
“…physiology has removed attention from the dramatic 70% fall in circulating DHEA which already occurs between the ages of 20 to 30 and 40 to 50 years (Migeon et al. 1957, Vermeulen & Verdonck 1976, Vermeulen et al. 1982, Orentreich et al. 1984, Bélanger et al. 1994, Labrie et al. 1997d) (Fig.”
BackgroundEffect of Hormone Replacement Therapy on Breast Cancer Risk: Estrogen Versus Estrogen Plus Progestin
Ross, R. K., Paganini‐Hill, A., Wan, P. C., & Pike, M. C. (2000) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200007000-00022 · Cited by 135
Labrie, F., Simard, J., Luu-The, V., Bélanger, A., & Pelletier, G. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90308-6 · Cited by 132
Self-citationKrazeisen, A., Breitling, R., Imai, K., Fritz, S., Möller, G., & Adamski, J. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01366-6 · Cited by 132
Schmitt, B. P., Wilt, T. J., Schellhammer, P. F., DeMasi, V., Sartor, O. A., Crawford, E. D., & Bennett, C. L. (2001) · Urology · doi:10.1016/s0090-4295(00)01086-4 · Cited by 131
Psychological Reactions and Sexual Life after Hysterectomy with and without Oophorectomy
Nathorst‐Böös, J., & von Schoultz, B. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000292735 · Cited by 127
Laughlin, G. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3561 · Cited by 127
Zumoff, B., Levin, J., Rosenfeld, R. S., Markham, M. J., Strain, G. W., & Fukushima, D. K. (1981) · PubMed · Cited by 123
Dehydroepiandrosterone Replacement in Aging Humans
Flynn, M. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.5.1527 · Cited by 123
A Review of the Prolonged Use of Estrogens and Androgens in Postmenopausal and Senile Osteoporosis
Henneman, P. H. (1957) · Archives of Internal Medicine · doi:10.1001/archinte.1957.00260110031005 · Cited by 122
Faure, N., Labrie, F., Lemay, A., Bélanger, A., Gourdeau, Y., Laroche, B., & Robert, G. (1982) · Fertility and Sterility · doi:10.1016/s0015-0282(16)46107-8 · Cited by 122
Self-citationThe Menopause: Health Implications and Clinical Management
Greendale, G. A., & Judd, H. L. (1993) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1993.tb06953.x · Cited by 120
Characterization, Expression, and Immunohistochemical Localization of 5α-Reductase in Human Skin
Luu-The, V., Sugimoto, Y., Puy, L., Labrie, Y., Solache, I. L., Singh, M., & Labrie, F. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12371766 · Cited by 118
Self-citationSubunit identity of the dimeric 17 beta-hydroxysteroid dehydrogenase from human placenta.
Lin, S., Yang, F. D., Jin, J. Z., Breton, R., Zhu, D.-W., Luu-The, V., & Labrie, F. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41984-9 · Cited by 117
Self-citationType 5 17β-hydroxysteroid dehydrogenase: its role in the formation of androgens in women
Luu-The, V., Dufort, I., Pelletier, G., & Labrie, F. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00425-1 · Cited by 115
Self-citationDown-regulation of estrogen receptors by androgens in the ZR-75-1 human breast cancer cell line.
POULIN, R., SIMARD, J., LABRIE, C., PETITCLERC, L., DUMONT, M., LAGACÉ, L., & LABRIE, F. (1989) · Endocrinology · doi:10.1210/endo-125-1-392 · Cited by 115
Self-citationSchriock, E. D., Buffington, C. K., Hubert, G. D., Kurtz, B. R., Kitabchi, A. E., Buster, J. E., & Givens, J. R. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-6-1329 · Cited by 115
Simard, J., Rhéaume, É., Sánchez, R., Laflamme, N., de Launoit, Y., Luu-The, V., van Seters, A. P., Gordon, R. D., Bettendorf, M., & Heinrich, U. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.5.8316254 · Cited by 114
Self-citationDHEA protects against visceral obesity and muscle insulin resistance in rats fed a high-fat diet
Hansen, P. A., Han, D. H., Nolte, L. A., Chen, M. W., & Holloszy, J. O. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.273.5.r1704 · Cited by 110
Field, C. S., Ory, S. J., Wahner, H. W., Herrmann, R. R., Judd, H. L., & Riggs, B. L. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(12)90897-2 · Cited by 109
Bennett, C., Tosteson, T., Schmitt, B. P., Weinberg, P. F., Ernstoff, M. S., & Ross, S. D. (1999) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500265 · Cited by 109
Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer.
BÉLANGER, A., BROCHU, M., & CLICHE, J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-812 · Cited by 108
Sex Hormones and Postmenopausal Breast Cancer: A Prospective Study in an Adult Community
Garland, C. F., Friedlander, N. J., Barrett-Connor, E. L., & Khaw, K. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116228 · Cited by 107
Greenblatt, R. B., Barfield, W. E., GARNER, J. F., Calk, G. L., & Harrod, J. P. (1950) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-10-12-1547 · Cited by 107
Dumont, M., Luu-The, V., Dupont, É., Pelletier, G., & Labrie, F. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12616131 · Cited by 104
Self-citationOrigin of Plasma Androstanediol Glucuronide in Men*
Moghissi, E. S., Ablan, F., & Horton, R. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-417 · Cited by 103
Inhibition of tumor development by dehydroepiandrosterone and related steroids.
Schwartz, A. G., Pashko, L., & Whitcomb, J. M. (1986) · Toxicologic Pathology · doi:10.1177/019262338601400312 · Cited by 101 · cited 1×
“Low circulating levels of DHEA-S and DHEA have also been found in patients with breast cancer (Zumoff et al. 1981) and DHEA has been found to exert anti-oncogenic activity in a series of animal models (Schwartz et al. 1986, Gordon et al. 1987, Li et al. 1993).”
BackgroundStudd, J. W. W., Collins, W. P., Chakravarti, S., Newton, R., Oram, D. H., & Parsons, A. (1977) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1977.tb12586.x · Cited by 99
Lipworth, L., Adami, H., Trichopoulos, D., Cartström, K., & Mantzoros, C. S. (1996) · Epidemiology · doi:10.1097/00001648-199601000-00017 · Cited by 96
Molecular cloning and amino acid sequence of the porcine 17β‐estradiol dehydrogenase
Leenders, F., Adamski, J., Husen, B., Thole, H. H., & Jungblut, P. W. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18860.x · Cited by 94
Savvas, M., Studd, J. W. W., Fogelman, I., Dooley, M., Montgomery, J., & Murby, B. (1988) · BMJ · doi:10.1136/bmj.297.6644.331 · Cited by 91
Molecular Characterization of a First Human 3(α→β)-Hydroxysteroid Epimerase
Huang, X.-F., & Luu-The, V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000562200 · Cited by 89
Self-citationde Launoit, Y., & Adamski, J. (1999) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0220227 · Cited by 89
Labrie, F., Candas, B., Gomez, J., & Cusan, L. (2002) · Urology · doi:10.1016/s0090-4295(02)01639-4 · Cited by 89
Self-citationPelletier, G., Luu-The, V., Tětu, B., & Labrie, F. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700602 · Cited by 88
Self-citationSix-month oral dehydroepiandrosterone supplementation in early and late postmenopause
Stomati, M., Monteleone, P., Casarosa, E., Quirici, B., Puccetti, S., Bernardi, F., Genazzani, A. D., Rovati, L., Luisi, M., & Genazzani, A. R. (2000) · Gynecological Endocrinology · doi:10.3109/09513590009167703 · Cited by 86
Cleary, M. P., & Zisk, J. (1986) · PubMed · Cited by 86
Turgeon, D. K., Carrier, J.-S., Lévesque, É., Beatty, B., Bélanger, A., & Hum, D. W. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3374 · Cited by 86
Human Types 1 and 3 3α-Hydroxysteroid Dehydrogenases: Differential Lability and Tissue Distribution1
Dufort, I., Labrie, F., & Luu-The, V. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7216 · Cited by 86
Self-citationNeed, A. G. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390010075007 · Cited by 85
Zhao, H., Rhgaurae, E., Trudel, C., Couët, J., Labrie, F., & Simard, J. (1990) · Endocrinology · doi:10.1210/endo-127-6-3237 · Cited by 82
Self-citationHormone replacement therapy for prevention and treatment of osteoporosis
Lindsay, R. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90380-8 · Cited by 81
Duan, W. R., Linzer, D. I. H., & Gibori, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15602 · Cited by 81
LABRIE, C., SIMARD, J., ZHAO, H. F., BELANGER, A., PELLETIER, G., & LABRIE, F. (1989) · Endocrinology · doi:10.1210/endo-124-6-2745 · Cited by 80
Self-citationEffects of Dehydroepiandrosterone Treatment in Rats with Diet-Induced Obesity
Mohan, P. F., Ihnen, J. S., Levin, B. E., & Cleary, M. P. (1990) · Journal of Nutrition · doi:10.1093/jn/120.9.1103 · Cited by 80
Akaza, H. (2004) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyh001 · Cited by 80
Acute Dehydroepiandrosterone (DHEA) Effects on Sexual Arousal in Postmenopausal Women
Hackbert, L., & Heiman, J. R. (2002) · Journal of Women s Health & Gender-Based Medicine · doi:10.1089/152460902753645290 · Cited by 79
Molecular basis of human 3β-hydroxysteroid dehydrogenase deficiency
Simard, J., Rhéaume, É., Mébarki, F., Sánchez, R., New, M. I., Morel, Y., & Labrie, F. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00043-y · Cited by 78
Self-citationSurgical Pathology of the Ovaries
Fox, H. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.325 · Cited by 78
Qiu, W., Zhou, M., Labrie, F., & Lin, S. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0032 · Cited by 77
Self-citationAndrogen replacement therapy in women
Cameron, D. R., & Braunstein, G. D. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.11.062 · Cited by 76
Li, S., Yan, X., B�langer, A., & Labrie, F. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00665681 · Cited by 70
Self-citationThe use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C. H., ROSNER, B. A., & Speizer, F. E. (1995) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199511000-00017 · Cited by 70
Dauvois, S., Geng, C.-S., Lévesque, C., Mérand, Y., & Labrie, F. (1991) · PubMed · Cited by 69
Self-citationKuttenn, F., Mowszowicz, I., Wright, F., Baudot, N., Jaffiol, C., ROBIN, M., & MAUVAIS-JARVIS, P. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-49-6-861 · Cited by 69
DHEA Treatment Reduces Fat Accumulation and Protects Against Insulin Resistance in Male Rats
Han, D., Hansen, P. A., Chen, M. M., & Holloszy, J. O. (1998) · The Journals of Gerontology Series A · doi:10.1093/gerona/53a.1.b19 · Cited by 65
LABRIE, Y., DUROCHER, F., LACHANCE, Y., TURGEON, C., SIMARD, J., LABRIE, C., & LABRIE, F. (1995) · DNA and Cell Biology · doi:10.1089/dna.1995.14.849 · Cited by 64
Self-citationThe Effects of Estrone (Ogen) on Spinal Bone Density of Postmenopausal Women
Harris, S. T. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400100060010 · Cited by 63
Couture, P., Thériault, C., Simard, J., & Labrie, F. (1993) · Endocrinology · doi:10.1210/endo.132.1.8380373 · Cited by 62
Self-citationBerger, L., Elalfy, M., Martel, C., & Labrie, F. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.02.018 · Cited by 62
Self-citationBiochemical and biological studies with 4-aza-steroidal 5α-reductase inhibitors
Liang, T., Rasmusson, G. H., & Brooks, J. R. (1983) · Journal of Steroid Biochemistry · doi:10.1016/s0022-4731(83)80051-x · Cited by 61
Dihydrotestosterone Is a Peripheral Paracrine Hormone
Horton, R. (1992) · Journal of Andrology · doi:10.1002/j.1939-4640.1992.tb01621.x · Cited by 60
Barbier, O., Lapointe, H., Alfy, M. E., Hum, D. W., & Bélanger, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7019 · Cited by 59
The Postmenopausal Ovary Is Not a Major Androgen-Producing Gland
Couzinet, B. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.10.5060 · Cited by 59
6 Peripheral androgens and the role of androstanediol glucuronide
Horton, R., & Lobo, R. A. (1986) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(86)80026-3 · Cited by 58
Archer, D., FURST, K., TIPPING, D., DAIN, M.-P., & VANDEPOL, C. (1999) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(99)00359-2 · Cited by 58
Zhu, D.-W., Lee, X., Breton, R., Ghosh, D. K., Pangborn, W. A., Duax, W. L., & Lin, S. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1578 · Cited by 57
Self-citationPostmenopausal hot flushes and their management
Lomax, P., & Schönbaum, E. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90060-q · Cited by 56
Structural Characterization and Expression of the Human Dehydroepiandrosterone Sulfotransferase Gene
LUU-THE, V., Dufort, I., Paquet, N., Reimnitz, G., & Labrie, F. (1995) · DNA and Cell Biology · doi:10.1089/dna.1995.14.511 · Cited by 56
Self-citationMAUVAIS-JARVIS, P., Bercovici, J. P., & Gauthier, F. (1969) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-29-3-417 · Cited by 56
Sherwin, B. B., & Gelfand, M. M. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(84)90746-4 · Cited by 55
Martel, C., Sourla, A., Pelletier, G., Labrie, C., Fournier, M., Picard, S., Li, S., Stojanovic, M. M., & Labrie, F. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1570433 · Cited by 55
Self-citationThe molecular biology of androgenic 17β-hydroxysteroid dehydrogenases
Andersson, S., Geissler, W. M., Patel, S., & Wu, L. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00039-3 · Cited by 54
Jędrzejuk, D., Mędraś, M., Milewicz, A., & Demissie, M. (2003) · The Aging Male · doi:10.1080/tam.6.3.151.156 · Cited by 53
Combined androgen blockade in prostate cancer: meta‐analyses and associated issues
Klotz, L. (2001) · British Journal of Urology · doi:10.1046/j.1464-410x.2001.02184.x · Cited by 52
Effect of estrone sulfate on postmenopausal bone loss
Genant, H. K., Baylink, D. J., Gallagher, J. C., Harris, S. T., Steiger, P., & Herber, M. (1991) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(91)90313-t · Cited by 52
Pelletier, G., Luu-The, V., Elalfy, M., Li, S., & Labrie, F. (2001) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0260011 · Cited by 52
Self-citationInfluence of testosterone and dihydrotestosterone on bone-matrix induced endochondral bone formation
Kapur, S. P., & Reddi, A. H. (1989) · Calcified Tissue International · doi:10.1007/bf02556469 · Cited by 50
Obesity in the dog: role of the adrenal steroid dehydroepiandrosterone (DHEA).
MacEwen, E. G., & Kurzman, I. D. (1991) · The Journal of Nutrition · doi:10.1093/jn/121.suppl_11.s51 · Cited by 49
Coffman, B. L., Tephly, T. R., Irshaid, Y. M., Green, M. D., Smith, C., Jackson, M. R., Wooster, R., & Burchell, B. (1990) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(90)90428-2 · Cited by 49
Pelletier, G., LUU-THE, V., HUANG, X.-F., Lapointe, H., & Labrie, F. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)62961-6 · Cited by 48
Self-citationSignal Transduction in Testicular Cells
(1996) · Springer eBooks · doi:10.1007/978-3-662-03230-5 · Cited by 48
Cited by
The Adaptive Calibration Model of stress responsivity
Del Giudice, M., Ellis, B. J., & Shirtcliff, E. A. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.11.007 · Cited by 1,373
Knop, E., Knop, N., Millar, T., Obata, H., & Sullivan, D. A. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6997c · Cited by 1,061
Sex, attachment, and the development of reproductive strategies
Del Giudice, M. (2009) · Behavioral and Brain Sciences · doi:10.1017/s0140525x09000016 · Cited by 598
Prevalence of Dry Eye Disease Among US Men: Estimates From the Physicians' Health Studies
Schaumberg, D. A. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.103 · Cited by 551
TFOS DEWS II Sex, Gender, and Hormones Report
Sullivan, D. A., Rocha, E. M., Aragona, P., Clayton, J. A., Ding, J., Golebiowski, B., Hampel, U., McDermott, A. M., Schaumberg, D. A., Srinivasan, S., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.04.001 · Cited by 434
Metadata
- Authors
- Labrie, F., Luu-The, V, Bélanger, A., Lin, S.-X., Simard, J., Pelletier, G., & Labrie, C.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2005-11
- Volume
- 187
- Issue
- 2
- Pages
- 169-196
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2106559777
- Cited by
- 451
- References
- 240
- FWCI
- 14.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.